Edition:
United States

John Miller

DSV raises offer for Panalpina in logistics tug of war

Feb 15 2019

ZURICH Danish logistics group DSV A/S sweetened its offer for Panalpina to $4.3 billion, with a tug of war escalating on Friday over the Swiss company as it weighs a separate deal with Kuwait's Agility Group.

Clariant shares drop as quarterly demand eases in Asia, Europe

Feb 13 2019

ZURICH Clariant missed fourth quarter profit and sales expectations on Wednesday due to softening demand in Asia and Europe, sending shares in the Swiss specialty chemicals maker lower.

Airopack's debt revamp collapses, cites accounting issues

Feb 11 2019

ZURICH Airopack's recapitalization plan collapsed as lenders including Apollo Global Management demanded repayment following the discovery of "inadequate sales and accounting practices", the Swiss aerosol packaging maker said on Monday.

UPDATE 2-Swiss Idorsia says 'stay tuned' for deals as it manages pipeline

Feb 07 2019

* CFO says J&J was fully aware of Actelion DOJ probe (Adds details about possible deals, comments from CEO, CFO, details about Actelion settlement)

Novartis CEO lauds Trump administration plan to overhaul rebates

Feb 07 2019

ZURICH Novartis AG Chief Executive Vas Narasimhan said his company's prescription drug prices have been "flat to negative" over the last three years, and directed blame for high costs for U.S. patients on industry middlemen that manage drug benefits.

Novartis CEO says U.S. rebate plan will return cash to patients

Feb 06 2019

ZURICH Novartis AG Chief Executive Vas Narasimhan said his company's prescription drug prices have been "flat to negative" over the last three years, and directed blame for high costs for U.S. patients on industry middlemen that manage drug benefits.

Novartis CEO says U.S. rebate plan will return cash to patients

Feb 06 2019

ZURICH, Feb 6 Novartis AG Chief Executive Vas Narasimhan said his company's prescription drug prices have been "flat to negative" over the last three years, and directed blame for high costs for U.S. patients on industry middlemen that manage drug benefits.

Switzerland's Sunrise in takeover talks for Liberty Global unit

Feb 06 2019

Switzerland's Sunrise Communications Group has confirmed it is in talks over a potential acquisition of broadband provider Liberty Global's Swiss business UPC Schweiz.

Roche adapts newer breast cancer drug in face of Herceptin imitations

Feb 05 2019

ZURICH Swiss drugmaker Roche aims to broaden the use of its Kadcyla breast cancer treatment as rivals crowd into the market with biosimilar copies of its older mainstay Herceptin.

World News